94 related articles for article (PubMed ID: 5475414)
1. [Electroencephalographic effects of fluphonazine decanoate].
Borenstein P; Cujo P; Dumaine A
Ann Med Psychol (Paris); 1970 Jul; 2(2):273-5. PubMed ID: 5475414
[No Abstract] [Full Text] [Related]
2. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
Auch W
Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
[No Abstract] [Full Text] [Related]
3. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and biological effects of fluphénazine décanoate. 35 cases].
Borenstein P; Dumaine A; Cujo P
Ann Med Psychol (Paris); 1970 Jul; 2(2):267-73. PubMed ID: 5475413
[No Abstract] [Full Text] [Related]
5. A controlled study of neuroleptization with fluphenazine hydrochloride injections.
Escobar JI; Barron A; Kiriakos R
J Clin Psychopharmacol; 1983 Dec; 3(6):359-62. PubMed ID: 6139394
[No Abstract] [Full Text] [Related]
6. Fluphenazine enanthate for the difficult psychotic patient.
Stewart AR; Lavallee B
Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574
[No Abstract] [Full Text] [Related]
7. Fluphenazine enanthate: a report of a clinical trial in psychotic patients.
Karkalas Y
Curr Ther Res Clin Exp; 1968 Apr; 10(4):196-200. PubMed ID: 4967873
[No Abstract] [Full Text] [Related]
8. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
Haumonté MT; Hoerdt HP
Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
[No Abstract] [Full Text] [Related]
9. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
Balon R; Kabesh Ia; Papezhova G
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experience with fluphenazine decanoate in psychoses].
Náhunek K; Rodová A; Svestka J
Act Nerv Super (Praha); 1970 Jan; 12(1):47-9. PubMed ID: 5460564
[No Abstract] [Full Text] [Related]
11. The use of depot neuroleptics: clinical experience in the United States.
Kane JM
J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
[TBL] [Abstract][Full Text] [Related]
12. A clinical evaluation of an injectable phenothiazine in the management of acute psychotic patients.
Verster JP
S Afr Med J; 1967 Jan; 41(4):83-4. PubMed ID: 5335781
[No Abstract] [Full Text] [Related]
13. New concept in phenothiazine therapy: fluphenazine enanthate and fluphenazine decanoate.
Sanseigne AJ; Yale HL; Hess SM; Burke JC; Horovitz ZP
Agressologie; 1968; 9(2):309-13. PubMed ID: 5675497
[No Abstract] [Full Text] [Related]
14. Depot fluphenazine: risk/benefit ratio.
Glazer WM
J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
[TBL] [Abstract][Full Text] [Related]
15. Correlation between electroencephalographic deviations following anti-psychotic drug treatment and the course of mental illness.
Dasberg H; Robinson S
Isr Ann Psychiatr Relat Discip; 1969 Nov; 7(2):185-200. PubMed ID: 5274357
[No Abstract] [Full Text] [Related]
16. [New method of chemotherapy in psychiatry with a neuroleptic with prolonged effect: fluphenazine enanthate].
Gayral L; Oules J; Fourny L; Grandmontagne O; Millet L; Peretti A; Roux G; Durou B
Sem Hop; 1968 Apr; 44(19):1298-300. PubMed ID: 4298956
[No Abstract] [Full Text] [Related]
17. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
[TBL] [Abstract][Full Text] [Related]
18. EEG changes after fluphenazine enanthate and decanoate based on analog power spectra and digital computer period analysis.
Keskiner A; Itil T; Han H; Hsu W; Ulett G
Psychopharmacologia; 1971; 20(3):230-41. PubMed ID: 5565254
[No Abstract] [Full Text] [Related]
19. Effects of long-acting injectable Prolixin in 23 psychotic patients.
Whittier JR; Korenyi C; Haydu GG; Goldschmidt L
Dis Nerv Syst; 1967 Jul; 28(7 Pt 1):459-61. PubMed ID: 4951982
[No Abstract] [Full Text] [Related]
20. Relationship between the behavioral and electroencephalographic effects of chlorpromazine and fluphenazine in rats.
Babbini M; Gaiardi M; Bartoletti M
Pharmacology; 1975; 13(6):520-5. PubMed ID: 1221434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
